Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Ac Immune SA | ACIU | Oct 18, 2024 | 3.13 | -2.49 |
Acacia Research | ACTG | Oct 18, 2024 | 4.73 | -0.84 |
Academy Sports and Outdoors | ASO | Oct 18, 2024 | 56.09 | +1.28 |
Acadia Healthcare | ACHC | Oct 18, 2024 | 52.03 | -12.29 |
Acadia Pharmaceuticals | ACAD | Oct 18, 2024 | 15.30 | +0.86 |
Acadia Realty Trust | AKR | Oct 18, 2024 | 24.74 | +1.19 |
Acasti Pharma, Inc. | ACST | Oct 18, 2024 | 3.33 | +1.47 |
Accel Entertainment | ACEL | Oct 18, 2024 | 11.32 | -1.31 |
Accelerate Diagnostics | AXDX | Oct 18, 2024 | 1.81 | +3.43 |
Accenture A | ACN | Oct 18, 2024 | 376.86 | +0.46 |
Acco Brands | ACCO | Oct 18, 2024 | 5.19 | -2.08 |
Accolade | ACCD | Oct 18, 2024 | 3.50 | -2.23 |
Accuray | ARAY | Oct 18, 2024 | 1.89 | +3.28 |
Acelyrin | SLRN | Oct 18, 2024 | 6.20 | -4.32 |
Achieve Life Sciences | ACHV | Oct 18, 2024 | 5.08 | +0.59 |
Achilles Therapeutics ADR | ACHL | Oct 18, 2024 | 1.00 | +1.01 |
ACI Worldwide | ACIW | Oct 18, 2024 | 50.66 | -2.46 |
Aclarion | ACON | Oct 18, 2024 | 0.18 | +4.52 |
Aclaris Therapeutics | ACRS | Oct 18, 2024 | 1.19 | +1.71 |
ACM Research A | ACMR | Oct 18, 2024 | 19.21 | +1.08 |
Acme United | ACU | Oct 18, 2024 | 41.20 | -5.89 |
ACNB | ACNB | Oct 18, 2024 | 44.10 | -0.14 |
ACRES Commercial Realty | ACR | Oct 18, 2024 | 15.67 | +2.15 |
ACRES Commercial Realty C Pref | ACR-C | Oct 18, 2024 | 24.89 | +0.28 |
ACRES Commercial Realty D Pref | ACR-D | Oct 18, 2024 | 23.35 | +0.41 |
Acri Capital Acquisition Unit | ACACU | Oct 18, 2024 | 12.94 | 0.00 |
Acrivon Therapeutics | ACRV | Oct 18, 2024 | 8.25 | +4.83 |
Actelis Networks | ASNS | Oct 18, 2024 | 1.45 | +3.57 |
Actinium Pharmaceuticals | ATNM | Oct 18, 2024 | 1.82 | +5.81 |
Active Bear ETF | HDGE | Oct 18, 2024 | 18.03 | -0.19 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.